Xiaofang Che
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 15
- Epigenetics and DNA Methylation 8
- Oncology 66
- Cancer Immunotherapy and Biomarkers 17
- Cancer-related Molecular Pathways 9
- Co-authors
- Xiujuan Qu (100 shared papers)Kezuo Hou (70 shared papers)Yunpeng Liu (61 shared papers)Yibo Fan (37 shared papers)Ce Li (41 shared papers)Zhi Li (37 shared papers)Ti Wen (21 shared papers)Ling Xu (27 shared papers)
- Journals
- Frontiers in Oncology (15 papers)Cell Biology International (9 papers)Biochemical and Biophysical Research Communications (6 papers)Experimental Cell Research (5 papers)International Journal of Oncology (5 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Xiaofang Che
156 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 116
- Cancer Research 1.0k
- Oncology 984
- Molecular Biology 2.0k
- Immunology 539
- Geriatrics and Gerontology 51
Countries citing papers authored by Xiaofang Che
This map shows the geographic impact of Xiaofang Che's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Che with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Che more than expected).
Fields of papers citing papers by Xiaofang Che
This network shows the impact of papers produced by Xiaofang Che. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Che. The network helps show where Xiaofang Che may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofang Che, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 154 | |
| 2 | 2019 | 104 | |
| 3 | 2020 | 100 | |
| 4 | 2013 | 93 | |
| 5 | 2018 | 74 | |
| 6 | 2003 | 62 | |
| 7 | 2006 | 60 | |
| 8 | 2018 | 59 | |
| 9 | 2015 | 59 | |
| 10 | 2014 | 59 | |
| 11 | Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas. | 1998 | 59 |
| 12 | 2020 | 56 | |
| 13 | 2017 | 55 | |
| 14 | 2007 | 54 | |
| 15 | 2020 | 53 | |
| 16 | 2018 | 50 | |
| 17 | 2014 | 47 | |
| 18 | 2020 | 47 | |
| 19 | 2015 | 47 | |
| 20 | 2017 | 46 |
About Xiaofang Che
Xiaofang Che is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 161 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (17 papers), Cancer Immunotherapy and Biomarkers (17 papers), MicroRNA in disease regulation (17 papers), RNA modifications and cancer (15 papers), Autophagy in Disease and Therapy (11 papers), Cancer-related Molecular Pathways (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Epigenetics and DNA Methylation (8 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (984 citations), Molecular Biology (2.0k citations), Immunology (539 citations) and Geriatrics and Gerontology (51 citations). Xiaofang Che has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Xiujuan Qu, Kezuo Hou, Yunpeng Liu, Yibo Fan, Ce Li, Zhi Li, Ti Wen, Ling Xu, Yunpeng Liu and Chunlei Zheng. Their work appears in journals such as Frontiers in Oncology, Cell Biology International, Biochemical and Biophysical Research Communications, Experimental Cell Research and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.